Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Lyra Therapeutics
480 Arsenal Way
Watertown, MA 02472
Phone: 617-393-4600

Lyra Therapeutics is a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, offering an alternative to conventional treatments or surgeries. The company's lead drug candidate, LYR-210, offers a novel approach for directing anti-inflammatory medicine deep into sinonasal tissues for up to six months of therapy. With proprietary expertise in drug development and materials science, Lyra is applying its transmucosal therapeutic system - comprised of drug administered through a polymeric matrix - with the goal of enabling therapeutic action at the site of inflammation in the sinonasal passages.

Key Contact
Name
Maria Palasis
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
09/26/18 $29,500,000 Series B ArrowMark Partners
Perceptive Advisors
RA Capital Management
Soleus Capital
undisclosed
01/29/20 $30,000,000 Series C ArrowMark Partners
Clifton Capital
Intersouth Partners
North Bridge Venture Partners
Perceptive Advisors
Polaris Partners
RA Capital Management
Soleus Capital
undisclosed